Should I buy or sell Humana stock right now?

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HUM shares. View HUM analyst ratings or view top-rated stocks .

What is Humana's stock price target for 2024?

15 Wall Street analysts have issued twelve-month price targets for Humana's shares. Their HUM share price targets range from $541.00 to $652.00. On average, they predict the company's share price to reach $590.28 in the next year. This suggests a possible upside of 22.6% from the stock's current price. View analysts price targets for HUM or view top-rated stocks among Wall Street analysts .

How have HUM shares performed in 2023?

Humana's stock was trading at $512.19 on January 1st, 2023. Since then, HUM stock has decreased by 6.0% and is now trading at $481.62. View the best growth stocks for 2023 here .

Are investors shorting Humana?

Humana saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 2,710,000 shares, a drop of 5.6% from the October 31st total of 2,870,000 shares. Based on an average daily volume of 1,030,000 shares, the days-to-cover ratio is presently 2.6 days. Currently, 2.2% of the company's stock are short sold. View Humana's Short Interest .

When is Humana's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024. View our HUM earnings forecast .

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) announced its quarterly earnings data on Wednesday, November, 1st. The insurance provider reported $7.78 EPS for the quarter, beating analysts' consensus estimates of $7.15 by $0.63. The insurance provider had revenue of $26.42 billion for the quarter, compared to the consensus estimate of $25.57 billion. Humana had a trailing twelve-month return on equity of 21.03% and a net margin of 2.95%. The firm's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.88 earnings per share. Read the conference call transcript .

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Tuesday, October 31st. Investors of record on Friday, December 29th will be paid a dividend of $0.885 per share on Friday, January 26th. This represents a $3.54 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Thursday, December 28th. Read our dividend analysis for HUM .

Is Humana a good dividend stock?

Humana (NYSE:HUM) pays an annual dividend of $3.54 per share and currently has a dividend yield of 0.74%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 14.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.27% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for HUM .

What ETFs hold Humana's stock?

ETFs with the largest weight of Humana (NYSE:HUM) stock in their portfolio include Optimize AI Smart Sentiment Event-Driven ETF (OAIE) , iShares U.S. Healthcare Providers ETF (IHF) , Hennessy Stance ESG Large Cap ETF (STNC) , First Trust Long/Short Equity ETF (FTLS) , Alpha Intelligent - Large Cap Value ETF (AILV) , Fidelity Disruptive Medicine ETF (FMED) , First Trust Growth Strength ETF (FTGS) and American Customer Satisfaction ETF (ACSI) .

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY23 earnings guidance on Friday, December, 1st. The company provided earnings per share (EPS) guidance of at least $28.25 for the period, compared to the consensus estimate of $28.28.

What is Bruce D. Broussard's approval rating as Humana's CEO?

1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com . Bruce D. Broussard has an approval rating of 87% among the company's employees.

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH) , NVIDIA (NVDA) , Walt Disney (DIS) , Visa (V) , Mastercard (MA) , Alibaba Group (BABA) , Boeing (BA) , Salesforce (CRM) , Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM) .

Who are Humana's major shareholders?

Humana's stock is owned by many different institutional and retail investors. Top institutional investors include Wellington Management Group LLP (5.47%), FMR LLC (4.05%), Morgan Stanley (1.66%), Ameriprise Financial Inc. (1.24%), Northern Trust Corp (1.08%) and Newport Trust Company LLC (1.06%). Insiders that own company stock include Bruce D Broussard , Christopher H Hunter , David A Jr/Ky Jones, David A Jr/Ky Jones , Jorge S Mesquita , Joseph C Ventura , Samir Deshpande , Susan M Diamond , Timothy Alan Wheatley , Timothy S Huval and William Kevin Fleming . View institutional ownership trends .

How do I buy shares of Humana?

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Does Humana have any subsidiaries?

The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II. Read More

Humana (HUM) Stock Price, News & Analysis

$481.62

+1.32 (+0.27%)

(As of 12/8/2023 08:57 PM ET)

Compare

Today's Range: $475.06
▼
$482.69
50-Day Range: $476.95
▼
$524.24
52-Week Range: $423.29
▼
$546.86

Volume: 1.08 million shs
Average Volume: 1.18 million shs
Market Capitalization: $59.29 billion

P/E Ratio: 19.97
Dividend Yield: 0.74%
Price Target: $590.28

Humana MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.73 Rating Score
Upside/Downside: 22.6% Upside
$590.28 Price Target
Short Interest: Healthy
2.21% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: -0.75
Upright™ Environmental Score
News Sentiment: 0.80
Based on 26 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 11.10%
From $28.28 to $31.42 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.14 out of 5 stars

Medical Sector

17th out of 942 stocks

Hospital & Medical Service Plans Industry

2nd out of 11 stocks

3.4

Analyst's Opinion

Consensus Rating
Humana has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 11 buy ratings, 4 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $590.28, Humana has a forecasted upside of 22.6% from its current price of $481.62.
Amount of Analyst Coverage
Humana has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
2.21% of the float of Humana has been sold short.
Short Interest Ratio / Days to Cover
Humana has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Humana has recently decreased by 5.57%, indicating that investor sentiment is improving significantly.

2.5

Dividend Strength

Dividend Yield
Humana has a dividend yield of 0.74%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Humana has been increasing its dividend for 7 years.
Dividend Coverage
The dividend payout ratio of Humana is 14.68%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Humana will have a dividend payout ratio of 11.27% next year. This indicates that Humana will be able to sustain or increase its dividend.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Humana has received a 52.17% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Health insurance services for individuals", "Health insurance services for groups", and "Physical retail of pharmaceuticals at a pharmacy" products. See details.
Environmental Sustainability
The Environmental Impact score for Humana is -0.75.

3.2

News and Social Media Coverage

News Sentiment
Humana has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 26 news articles for Humana this week, compared to 12 articles on an average week.
Search Interest
35 people have searched for HUM on MarketBeat in the last 30 days. This is an increase of 9% compared to the previous 30 days.
MarketBeat Follows
Only 64 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -49% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Humana insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.32% of the stock of Humana is held by insiders.
Percentage Held by Institutions
91.86% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Humana are expected to grow by 11.10% in the coming year, from $28.28 to $31.42 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Humana is 19.97, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 108.55.
Price to Earnings Ratio vs. Sector
The P/E ratio of Humana is 19.97, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 94.60.
Price to Earnings Growth Ratio
Humana has a PEG Ratio of 1.26. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Humana has a P/B Ratio of 3.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Humana Stock (NYSE:HUM)

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

HUM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HUM Stock News Headlines

December 2, 2023 | marketbeat.com

Mega merger in the works? Humana, Cigna explore big deal (HUM)

Humana and Cigna are exploring a merger, aiming to conclude the deal before year-end, creating a healthcare giant with a potential market value of $137 billion.

December 10, 2023 | marketwatch.com

: Cigna raises stock buyback by $10 billion, will reportedly drop bid to buy Humana

December 11, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

December 10, 2023 | msn.com

Report: Cigna calls off massive merger with Louisville-based Humana

December 10, 2023 | cnbc.com

Cigna abandons pursuit of Humana, plans $10 billion share buyback, sources say

December 10, 2023 | msn.com

A merger between Cigna and Humana that would have created a gigantic $140 billion healthcare conglomerate has been called off

December 10, 2023 | finance.yahoo.com

Cigna pulls out of blockbuster deal to create insurance giant with Humana

December 10, 2023 | fortune.com

Cigna drops bid to buy Humana, plans $10 billion share buyback

December 11, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

December 10, 2023 | finance.yahoo.com

US health insurer Cigna scraps deal to buy Humana

December 10, 2023 | finance.yahoo.com

Cigna ends attempt to negotiate acquisition of Humana - source

December 10, 2023 | news.yahoo.com

US health insurer Cigna scraps deal to buy Humana -WSJ

December 10, 2023 | bloomberg.com

Cigna to Call Off Humana Deal, Plans $10 Billion Buyback

December 10, 2023 | msn.com

Cigna abandons pursuit of Humana, plans $10 billion share buyback -sources

December 10, 2023 | finance.yahoo.com

Cigna Calls Off Humana Pursuit, Plans Big Stock Buyback

December 10, 2023 | bloomberg.com

Humana Disbands Board’s Executive Committee Amid Cigna Merger Talks

December 8, 2023 | ca.news.yahoo.com

Humana-Paredes, Wilkerson lose to Americans in Volleyball Beach Pro Tour quarterfinal

December 7, 2023 | bizjournals.com

Greater Louisville Inc., Humana Foundation pair up on grant awards to boost mental health access

December 7, 2023 | businesswire.com

Humana Sets Ambitious Science-Based Environmental Targets to Reduce Emissions by 54.6 Percent

December 6, 2023 | bizjournals.com

OPINION: Entrepreneurial approach of Humana co-founder David Jones Sr. transcends decades

December 6, 2023 | finance.yahoo.com

Humana Announces $500K Investment in the Virginia Health Care Foundation to Boost Behavioral Health Workforce Development and Support

December 5, 2023 | finance.yahoo.com

Texas A&M University-Mays Business School and Humana Announce Seventh Annual Healthcare Analytics Case Competition Winners

December 5, 2023 | finance.yahoo.com

Humana Foundation Awards Health Equity Research Grants Equal to $1 Million to Three University Partners

December 5, 2023 | americanbankingnews.com

Short Interest in Humana Inc. (NYSE:HUM) Decreases By 5.6%

December 3, 2023 | seekingalpha.com

Catalyst Watch: Cigna, Humana Deal Would Face Regulatory Hurdles

December 2, 2023 | seekingalpha.com

Humana gains amid a report of its corporate jet visting Arkansas, home of Walmart

December 2, 2023 | americanbankingnews.com

Humana Inc. (NYSE:HUM) Given Consensus Rating of "Moderate Buy" by Brokerages

See More Headlines

Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 10/27 Dividend: 9/28/2023
Dividend Payable: 10/27/2023
Last Earnings: 11/01/2023
Today: 12/11/2023
Ex-Dividend for 1/26 Dividend: 12/28/2023
Fiscal Year End: 12/31/2023
Dividend Payable: 1/26/2024
Next Earnings (Estimated): 2/07/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Hospital & medical service plans
Sub-Industry: Managed Health Care
Sector: Medical
Current Symbol: NYSE:HUM
CUSIP: 44485910
CIK: 49071
Web: www.humana.com
Phone: (502) 580-1000
Fax: 502-580-3639
Employees: 67,100
Year Founded: 1961

Price Target and Rating

Average Stock Price Target: $590.28
High Stock Price Target: $652.00
Low Stock Price Target: $541.00
Potential Upside/Downside: +22.6%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.73
Research Coverage: 15 Analysts

Profitability

EPS (Most Recent Fiscal Year): $24.12
Trailing P/E Ratio: 19.97
Forward P/E Ratio: 17.03
P/E Growth: 1.26
Net Income: $2.81 billion
Net Margins: 2.95%
Pretax Margin: 3.81%
Return on Equity: 21.03%
Return on Assets: 6.59%

Debt

Debt-to-Equity Ratio: 0.56
Current Ratio: 1.37
Quick Ratio: 1.37

Sales & Book Value

Annual Sales: $92.87 billion
Price / Sales: 0.64
Cash Flow: $32.11 per share
Price / Cash Flow: 15.00
Book Value: $121.41 per share
Price / Book: 3.97

Miscellaneous

Outstanding Shares: 123,110,000
Free Float: 122,717,000
Market Cap: $59.29 billion
Optionable: Optionable
Beta: 0.55

Social Links

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Bruce Dale Broussard (Age 61)
President, CEO & Director
Comp: $4.77M
Ms. Susan Marie Diamond (Age 49)
Chief Financial Officer
Comp: $1.9M
Mr. Timothy S. Huval (Age 57)
Chief Administrative Officer
Comp: $1.68M
Mr. Joseph C. Ventura (Age 46)
Chief Legal Officer
Comp: $1.54M
Mr. Timothy Alan Wheatley (Age 55)
Advisor
Comp: $1.66M
Mr. John-Paul William Felter (Age 40)
Senior VP, Chief Accounting Officer, Principal Accounting Officer & Controller
Mr. Samir M. Deshpande (Age 58)
Chief Information Officer
Lisa M. Stoner
Vice President of Investor Relations
Dr. Vishal Agrawal (Age 49)
Chief Strategy & Corporate Development Officer
Ms. Jennifer Mumby Bazante (Age 58)
Chief Marketing Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy Humana Stock? HUM Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Humana was last updated on Sunday, December 10, 2023 at 7:03 PM.

Pros

Here are some ways that investors could benefit from investing in Humana Inc.:

Humana Inc. is a well-established health and well-being company in the United States.
It operates through two segments, Insurance and Healthcare Services, providing a diversified range of products and services.
Humana Inc. has a strong track record of financial performance and has consistently delivered positive results.
The company offers innovative healthcare solutions and is constantly adapting to the changing needs of the market.
One reason to invest in Humana Inc. is its current stock price, which can provide potential returns for investors.

Cons

Investors should be bearish about investing in Humana Inc. for these reasons:

Humana Inc. faces regulatory risks and uncertainties in the highly regulated healthcare industry.
The company operates in a competitive market with other major players, which may impact its market share and profitability.
Changes in government policies and healthcare regulations can have a significant impact on Humana Inc.'s business operations.
Investing in healthcare companies involves inherent risks related to the unpredictable nature of healthcare trends and developments.
While Humana Inc. has a strong presence in the United States, its international operations may face challenges and risks.

HUM Stock Analysis - Frequently Asked Questions

Should I buy or sell Humana stock right now?: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last twelve months. There are currently 4 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HUM shares.
View HUM analyst ratings or view top-rated stocks.
What is Humana's stock price target for 2024?: 15 Wall Street analysts have issued twelve-month price targets for Humana's shares. Their HUM share price targets range from $541.00 to $652.00. On average, they predict the company's share price to reach $590.28 in the next year. This suggests a possible upside of 22.6% from the stock's current price.
View analysts price targets for HUM or view top-rated stocks among Wall Street analysts.
How have HUM shares performed in 2023?: Humana's stock was trading at $512.19 on January 1st, 2023. Since then, HUM stock has decreased by 6.0% and is now trading at $481.62.
View the best growth stocks for 2023 here.
Are investors shorting Humana?: Humana saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 2,710,000 shares, a drop of 5.6% from the October 31st total of 2,870,000 shares. Based on an average daily volume of 1,030,000 shares, the days-to-cover ratio is presently 2.6 days. Currently, 2.2% of the company's stock are short sold.
View Humana's Short Interest.
When is Humana's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our HUM earnings forecast.
How were Humana's earnings last quarter?: Humana Inc. (NYSE:HUM) announced its quarterly earnings data on Wednesday, November, 1st. The insurance provider reported $7.78 EPS for the quarter, beating analysts' consensus estimates of $7.15 by $0.63. The insurance provider had revenue of $26.42 billion for the quarter, compared to the consensus estimate of $25.57 billion. Humana had a trailing twelve-month return on equity of 21.03% and a net margin of 2.95%. The firm's quarterly revenue was up 15.9% on a year-over-year basis. During the same quarter last year, the firm posted $6.88 earnings per share.
Read the conference call transcript.
How often does Humana pay dividends? What is the dividend yield for Humana?: Humana announced a quarterly dividend on Tuesday, October 31st. Investors of record on Friday, December 29th will be paid a dividend of $0.885 per share on Friday, January 26th. This represents a $3.54 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Thursday, December 28th.
Read our dividend analysis for HUM.
Is Humana a good dividend stock?: Humana (NYSE:HUM) pays an annual dividend of $3.54 per share and currently has a dividend yield of 0.74%. The company has been increasing its dividend for 7 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 14.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, HUM will have a dividend payout ratio of 11.27% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for HUM.

What ETFs hold Humana's stock?: ETFs with the largest weight of Humana (NYSE:HUM) stock in their portfolio include Optimize AI Smart Sentiment Event-Driven ETF (OAIE), iShares U.S. Healthcare Providers ETF (IHF), Hennessy Stance ESG Large Cap ETF (STNC), First Trust Long/Short Equity ETF (FTLS), Alpha Intelligent - Large Cap Value ETF (AILV), Fidelity Disruptive Medicine ETF (FMED), First Trust Growth Strength ETF (FTGS) and American Customer Satisfaction ETF (ACSI).
What guidance has Humana issued on next quarter's earnings?: Humana issued an update on its FY23 earnings guidance on Friday, December, 1st. The company provided earnings per share (EPS) guidance of at least $28.25 for the period, compared to the consensus estimate of $28.28.
What is Bruce D. Broussard's approval rating as Humana's CEO?: 1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees.
What other stocks do shareholders of Humana own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), Boeing (BA), Salesforce (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).
Who are Humana's major shareholders?: Humana's stock is owned by many different institutional and retail investors. Top institutional investors include Wellington Management Group LLP (5.47%), FMR LLC (4.05%), Morgan Stanley (1.66%), Ameriprise Financial Inc. (1.24%), Northern Trust Corp (1.08%) and Newport Trust Company LLC (1.06%). Insiders that own company stock include Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, David A Jr/Ky Jones, Jorge S Mesquita, Joseph C Ventura, Samir Deshpande, Susan M Diamond, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming.
View institutional ownership trends.
How do I buy shares of Humana?: Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
Does Humana have any subsidiaries?: The following companies are subsidiares of Humana: 154th Street Medical Plaza, 516-526 West Main Street Condominium Council of Co-Owners, 54th Street Medical Plaza, American Eldercare, American Eldercare of North Florida, Anvita Health, Arcadian Health Plan, Arcadian Management Services, Atlantis Physician Group, CAC Medical Center Holdings, CAC-Florida Medical Centers, CDO 1, CDO 2, CHA HMO, CHA Service Company, Care Partners Home Care, CareNetwork, CarePlus Health, CarePlus Health Plans, Cariten Health Plan Inc., Certify Data Systems, CompBenefits, CompBenefits Company, CompBenefits Corporation, CompBenefits Dental, CompBenefits Direct, CompBenefits Insurance Company, Complex Clinical Management, Concentra Managed Care, Continucare Corporation, Continucare MDHC, Continucare MSO, Continucare Medical Management, Dental Care Plus Management, DentiCare, Emphesys, Emphesys Insurance Company, Enclara Healthcare, FPG, FPG Acquisition Corp., FPG Acquisition Holdings Corp., FPG Senior Services, Family Physicians of Winter Park, Go365, HUM Provider Holdings, HUM-e-FL, Harris Rothenberg International, Health Value Management, Humana Active Outlook, Humana At Home (Dallas), Humana At Home (Houston), Humana At Home (San Antonio), Humana At Home (TLC), Humana At Home 1, Humana Behavioral Health, Humana Benefit Plan of Illinois, Humana Dental Company, Humana Digital Health and Analytics Platform Services, Humana EAP and Work-Life Services of California, Humana Employers Health Plan of Georgia, Humana Government Business, Humana Health Benefit Plan of Louisiana, Humana Health Company of New York, Humana Health Insurance Company of Florida, Humana Health Plan, Humana Health Plan of California, Humana Health Plan of Ohio, Humana Health Plan of Texas, Humana Health Plans of Puerto Rico, Humana Healthcare Research, Humana Inc., Humana Innovation Enterprises, Humana Insurance Company, Humana Insurance Company of Kentucky, Humana Insurance Company of New York, Humana Insurance of Puerto Rico, Humana Management Services of Puerto Rico, Humana MarketPOINT, Humana MarketPOINT of Puerto Rico, Humana Medical Plan, Humana Medical Plan of Michigan, Humana Medical Plan of Pennsylvania, Humana Medical Plan of Utah, Humana Pharmacy, Humana Pharmacy Solutions, Humana Regional Health Plan, Humana Veterans Healthcare Services, Humana WellWorks LLC, Humana Wisconsin Health Organization Insurance Corporation, Humana at Home, HumanaDental, HumanaDental Insurance Company, Humco, Hummingbird Coaching Systems LLC, Independent Care Health Plan, KMG America, Kindred Healthcare, MCCI Group Holdings, MCCI Holdings, MCCI Medical Group, MCCI Specialty, MCCI/Lifetime of Aventura, MD Care, METCARE of Florida, Managed Care Indemnity, Medical Care Consortium Incorporated of Texas, MetCare, Metropolitan Health Networks, Naples Health Care Specialists, North Region Providers, Nursing Solutions, OSF HealthCare, PHP Companies, Partners in Integrated Care, Preferred Health Partnership, Preservation on Main, Primary Care Holdings, Primary Care Holdings II, Primary Care Specialists of the Palm Beaches, RMA Medical Centers of Florida, RMA Medical Group of Florida, ROHC, SeniorBridge, SeniorBridge Family Companies (CT), SeniorBridge Family Companies (FL), SeniorBridge Family Companies (IN), SeniorBridge Family Companies (MO), SeniorBridge Family Companies (NY), SeniorBridge-Florida, Texas Dental Plans, The Dental Concern, Transcend Population Health Management, and Transcend Population Health Management II.
Read More

This page (NYSE:HUM) was last updated on 12/11/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Humana (HUM) Stock Price, News & Analysis

Humana MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Humana Stock (NYSE:HUM)

HUM Stock Price History

HUM Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

Should I Buy Humana Stock? HUM Pros and Cons Explained

Pros

Cons

HUM Stock Analysis - Frequently Asked Questions

Overall MarketRank^™